TRT on TikTok: separating real hormone science from bro-science

What did @trtsgtmaj2 actually say?

The creator, a self-described retired Marine promoting a telehealth clinic, listed a string of benefits from testosterone replacement therapy, including surging energy, improved mental clarity, reduced anxiety, higher libido, muscle gain, and fat loss. When it came to downsides, he offered exactly one: "a little bit of water retention" that resolved early on. His framing was direct: "The only negative side effect I have ever experienced over the last several years" was that brief bloating. He credited a correctly structured protocol for his clean experience and pushed viewers to book through his clinic rather than attempt TRT independently.

To be clear, he is not making a clinical claim about all patients. He is reporting his personal experience. But the video is framed as an explainer on TRT side effects broadly, and that framing matters when 13,000 people are watching to learn what they might face.

Does the science back this up?

Some of his reported benefits are well-supported. The claim that TRT improves energy, libido, mood, and body composition in men with confirmed hypogonadism is not controversial. But the idea that the side effect profile reduces to minor, transient water retention does not survive a serious look at the literature.

The TRAVERSE trial (Lincoff et al., 2023, New England Journal of Medicine), the largest cardiovascular safety study on TRT to date, found non-inferior cardiovascular outcomes compared to placebo in men with hypogonadism and elevated cardiovascular risk. That is reassuring but limited. The same trial documented meaningful rates of atrial fibrillation, acute kidney injury, and pulmonary embolism in the testosterone group. Erythrocytosis (elevated red blood cell count) remains one of the most commonly documented adverse effects, appearing in roughly 20-30% of TRT users depending on dose and formulation (Bhasin et al., 2010, Journal of Clinical Endocrinology and Metabolism). Testicular atrophy and suppression of natural testosterone production via the hypothalamic-pituitary-gonadal axis are predictable pharmacological consequences, not rare events. Fertility impairment is also well-documented and often irreversible without intervention (Coward et al., 2013, Journal of Urology).

What did they get wrong (or right)?

Credit where it is due: the benefits he described, better mood, more energy, stronger libido, improved body composition, are legitimate outcomes for men with clinically low testosterone who are properly treated. Those are not invented. Multiple systematic reviews back them up.

What he got wrong is the omission. Framing TRT side effects as essentially nonexistent, then attributing that to a correct protocol, is misleading in a meaningful way. It implies that side effects are mostly a product of user error, which is not what the data shows. Erythrocytosis, for example, is a dose-dependent physiological response, not a protocol mistake. Testicular atrophy is a near-universal consequence of exogenous testosterone use, not a sign that someone did something wrong.

The sales pitch woven through the video also muddies the educational value. Repeatedly directing viewers to "comment T" and implying his clinic uniquely delivers side-effect-free results is not a neutral health explainer. It is advertising dressed as education, and viewers deserve to know the difference.

What should you actually know?

TRT is a legitimate, effective treatment for men with diagnosed hypogonadism, and the benefits the creator described are real for appropriate candidates. But a complete picture of the side effect profile includes erythrocytosis, potential impacts on fertility, testicular volume reduction, sleep apnea worsening, and in some populations, elevated cardiovascular risk markers. These are not fringe concerns. They are standard items on any endocrinologist's monitoring checklist.

The TRAVERSE trial (Lincoff et al., 2023) offers some reassurance on major cardiovascular events, but it also confirms that TRT is not a side-effect-free intervention. Monitoring hematocrit, PSA, and lipid panels is standard of care for a reason.

If you are considering TRT, the right starting point is a full hormonal workup with a licensed provider who will look at your specific numbers, health history, and goals. One person's clean experience on a well-managed protocol is useful context. It is not a substitute for informed consent.